Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details)

v3.23.2
Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 147,707 43,996 147,707 43,996
Non-vested restricted stock awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 1,979,578 1,192,447 1,979,578 1,192,447
Non-vested restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 1,300,494   1,300,494  
Common stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 240,100 240,100 240,100 240,100
Convertible debt        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 583,333   583,333